Pharmaris products are available through all major distributors, wholesalers and directly through the Pharmaris warehouse.
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-DOMPERIDONE | 10 mg | 02462834 | Domperidone Maleate | APO Domperidone | Modifier of Upper Gastrointestinal Motility |
Indication | Pack Size | UPC |
---|---|---|
PRZ-DOMPERIDONE (domperidone maleate) is indicated in the symptomatic management of upper gastrointestinal motility disorders associated with chronic and subacute gastritis and diabetic gastroparesis. PRZ-DOMPERIDONE may also be used to prevent gastrointestinal symptoms associated with the use of dopamine agonist antiparkinsonian agents. | 500 Tablets (Bottle) | 055668000701 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Round Biconvex | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-AMLODIPINE | 2.5 mg | 02522500 | AMLODIPINE BESYLATE | NORVASC | Antihypertensive-Antianginal Agent |
Indication | Pack Size | UPC |
---|---|---|
The treatment of mild to moderate essential hypertension. The management of chronic stable angina (effort-associated angina) in patients who remain symptomatic despite adequate doses of beta-blockers and/or organic nitrates or who cannot tolerate those agents. | 100 Tablets (Bottle) | 055668000718 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Round | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-AMLODIPINE | 5 mg | 02522519 | AMLODIPINE BESYLATE | NORVASC | Antihypertensive-Antianginal Agent |
Indication | Pack Size | UPC |
---|---|---|
The treatment of mild to moderate essential hypertension. The management of chronic stable angina (effort-associated angina) in patients who remain symptomatic despite adequate doses of beta-blockers and/or organic nitrates or who cannot tolerate those agents. | 500 Tablets (Bottle) | 055668000725 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Elongated Octagon | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-AMLODIPINE | 10 mg | 02522527 | AMLODIPINE BESYLATE | NORVASC | Antihypertensive-Antianginal Agent |
Indication | Pack Size | UPC |
---|---|---|
The treatment of mild to moderate essential hypertension. The management of chronic stable angina (effort-associated angina) in patients who remain symptomatic despite adequate doses of beta-blockers and/or organic nitrates or who cannot tolerate those agents. | 500 Tablets (Bottle) | 055668000732 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Elongated Octagon | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ATORVASTATIN | 10 mg | 02521555 | ATORVASTATIN CALCIUM | LIPITOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 100 Tablets (Bottle) | 500 tablets (055668000183) 100 tablets (055668000923) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ATORVASTATIN | 20 mg | 02521563 | ATORVASTATIN CALCIUM | LIPITOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 100 Tablets (Bottle) | 500 tablets (055668000190) 100 tablets (055668000930) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ATORVASTATIN | 40 mg | 02521571 | ATORVASTATIN CALCIUM | LIPITOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 100 Tablets (Bottle) | 500 tablets (055668000206) 100 tablets (055668000947) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ATORVASTATIN | 80 mg | 02521598 | ATORVASTATIN CALCIUM | LIPITOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 100 Tablets (Bottle) | 100 tablets (055668000213) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-OLMESARTAN/ HCTZ | 20 mg / 12.5 mg | 02526468 | OLMESARTAN MEDOXOMIL/ HYDROCHLOROTHIAZIDE | OLMETEC PLUS | Angiotensin II AT1 Receptor Blocker – Diuretic |
Indication | Pack Size | UPC |
---|---|---|
PRZ-OLMESARTAN/HCTZ (Olmesartan Medoxomil and Hydrochlorothiazide) is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate. | 100 Tablets (Bottle) | 100 tablets (055668000503) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Beige | Beveled Edge Round | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-OLMESARTAN/ HCTZ | 40 mg / 12.5 mg | 02526476 | OLMESARTAN MEDOXOMIL/ HYDROCHLOROTHIAZIDE | OLMETEC PLUS | Angiotensin II AT1 Receptor Blocker – Diuretic |
Indication | Pack Size | UPC |
---|---|---|
PRZ-OLMESARTAN/HCTZ (Olmesartan Medoxomil and Hydrochlorothiazide) is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate. | 100 Tablets (Bottle) | 100 tablets (055668000510) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Beige | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-OLMESARTAN/ HCTZ | 40 mg / 25 mg | 02526484 | OLMESARTAN MEDOXOMIL/ HYDROCHLOROTHIAZIDE | OLMETEC PLUS | Angiotensin II AT1 Receptor Blocker – Diuretic |
Indication | Pack Size | UPC |
---|---|---|
PRZ-OLMESARTAN/HCTZ (Olmesartan Medoxomil and Hydrochlorothiazide) is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate. | 100 Tablets (Bottle) | 100 tablets (055668000527) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pink | Oval | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ROSUVASTATIN | 5 mg | 02505576 | ROSUVASTATIN CALCIUM | CRESTOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 90 Tablets (Bottle) | 500 tablets (055668000121) 90 tablets (055668000114) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Yellow | Round, biconvex, beveled edge | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ROSUVASTATIN | 10 mg | 02505584 | ROSUVASTATIN CALCIUM | CRESTOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 90 Tablets (Bottle) | 500 tablets (055668000145) 90 tablets (055668000138) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pink | Round, biconvex, beveled edge | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ROSUVASTATIN | 20 mg | 02505592 | ROSUVASTATIN CALCIUM | CRESTOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 Tablets (Bottle) 90 Tablets (Bottle) | 500 tablets (055668000169) 90 tablets (055668000152) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pink | Round, biconvex | Oral | No |
*images are not actual size
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-ROSUVASTATIN | 40 mg | 02505606 | ROSUVASTATIN CALCIUM | CRESTOR | Lipid Metabolism Regulator |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 90 Tablets (Bottle) | 90 tablets (055668000176) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pink | Oval, biconvex | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-SILDENAFIL | 25 mg | 02505150 | SILDENAFIL CITRATE | VIAGRA | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
For the treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. | 4 Tablets (Blister) 30 Tablets (Bottle) | 4 tablets (055668000008) 30 tablets (055668000015) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pale Blue to Blue | Diamond | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-SILDENAFIL | 50 mg | 02505169 | SILDENAFIL CITRATE | VIAGRA | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
For the treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. | 4 Tablets (Blister) 30 Tablets (Bottle) | 4 tablets (055668000039) 30 tablets (055668000046) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pale Blue to Blue | Diamond | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-SILDENAFIL | 100 mg | 02468557 | SILDENAFIL CITRATE | VIAGRA | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
For the treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. | 4 Tablets (Blister) 30 Tablets (Bottle) | 4 tablets (055668000060) 30 tablets (055668000077) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Pale Blue to Blue | Diamond | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-SOLIFENACIN | 5 mg | 02468557 | SOLIFENACIN SUCCINATE | VESICARE | Urinary antispasmodic |
Indication | Pack Size | UPC |
---|---|---|
Treatment of overactive bladder in adults with symptoms of urge urinary incontinence, urinary urgency and urinary frequency | 90 Tablets (Bottle) | 90 Tablets (628110761033) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Light Yellow | Round, biconvex | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-SOLIFENACIN | 10 mg | 02493047 | SOLIFENACIN SUCCINATE | VESICARE | Urinary antispasmodic |
Indication | Pack Size | UPC |
---|---|---|
Treatment of overactive bladder in adults with symptoms of urge urinary incontinence, urinary urgency and urinary frequency | 90 Tablets (Bottle) | 90 Tablets (628110761057) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Light Pink | Round, biconvex | Oral | No |
*images are not actual size
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-TADALAFIL | 2.5 mg | 02512262 | TADALAFIL | CIALIS | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
PRZ-TADALAFIL (tadalafil) is indicated for the treatment of erectile dysfunction (ED) in men. PRZ-TADALAFIL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). PRZ-TADALAFIL is indicated for the treatment of ED and the signs and symptoms of benign prostatic hyperplasia (ED/BPH). | 30 Tablets (Bottle) 4 Tablets (Blister) | 30 Tablets (055668000299) 4 Tablets (055668000244) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Yellow | Almond | Oral | No |
*images are not actual size
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-TADALAFIL | 5 mg | 02512270 | TADALAFIL | CIALIS | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
PRZ-TADALAFIL (tadalafil) is indicated for the treatment of erectile dysfunction (ED) in men. PRZ-TADALAFIL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). PRZ-TADALAFIL is indicated for the treatment of ED and the signs and symptoms of benign prostatic hyperplasia (ED/BPH). | 30 Tablets (Bottle) 4 Tablets (Blister) | 30 Tablets (055668000268) 4 Tablets (055668000220) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Yellow | Almond | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-TADALAFIL | 10 mg | 02512289 | TADALAFIL | CIALIS | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
PRZ-TADALAFIL (tadalafil) is indicated for the treatment of erectile dysfunction (ED) in men. PRZ-TADALAFIL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). PRZ-TADALAFIL is indicated for the treatment of ED and the signs and symptoms of benign prostatic hyperplasia (ED/BPH). | 30 Tablets (Bottle) 4 Tablets (Blister) | 30 Tablets (055668000305) 4 Tablets (055668000251) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Yellow | Almond | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-TADALAFIL | 20 mg | 02512297 | TADALAFIL | CIALIS | cGMP-Specific Phosphodiesterase Type 5 Inhibitor |
Indication | Pack Size | UPC |
---|---|---|
PRZ-TADALAFIL (tadalafil) is indicated for the treatment of erectile dysfunction (ED) in men. PRZ-TADALAFIL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). PRZ-TADALAFIL is indicated for the treatment of ED and the signs and symptoms of benign prostatic hyperplasia (ED/BPH). | 30 Tablets (Bottle) 4 Tablets (Blister) | 30 Tablets (055668000282) 4 Tablets (055668000237) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Yellow | Almond | Oral | No |
*images are not actual size
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-AMOXICILLIN | 250 mg | 02532042 | AMOXICILLIN TRIHYDRATE | APO-AMOXI | Antibiotic |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 capsules (Bottle) 100 Capsules (Bottle) | 500 capsules (055668000602) 100 capsules (055668000954) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Maroon coloured cap and yellow coloured body containing off white granular powder | Hard Gelatin capsules | Oral | No |
*images are not actual size
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-AMOXICILLIN | 500 mg | 02532050 | AMOXICILLIN TRIHYDRATE | APO-AMOXI | Antibiotic |
Indication | Pack Size | UPC |
---|---|---|
Please Refer to Product Monograph | 500 capsules (Bottle) 100 Capsules (Bottle) | 500 capsules (055668000619) 100 capsules (055668000961) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
Maroon coloured cap and yellow coloured body containing off white granular powder | Hard Gelatin capsules | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-METFORMIN | 500 mg | 02531895 | METFORMIN HYDROCHLORIDE | GLUCOPHAGE | Antihyperglycemic Agent |
Indication | Pack Size | UPC |
---|---|---|
PRZ-METFORMIN (metformin HCl) is indicated to improve glycemic control in adult patients with responsive, stable, mild, non-ketosis prone, type 2 diabetes mellitus as an adjunct to proper dietary management, exercise, and weight reduction, or when insulin therapy is not appropriate. PRZ-METFORMIN can be used as monotherapy or in combination with other antidiabetic agents | 100 Tablets (Bottle) 360 Tablets (Bottle) 500 Tablets (Bottle) | 100 Tablets (055668000794) 500 Tablets (055668001081) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Round, biconvex | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-METFORMIN | 850 mg | 02531909 | METFORMIN HYDROCHLORIDE | GLUCOPHAGE | Antihyperglycemic Agent |
Indication | Pack Size | UPC |
---|---|---|
PRZ-METFORMIN (metformin HCl) is indicated to improve glycemic control in adult patients with responsive, stable, mild, non-ketosis prone, type 2 diabetes mellitus as an adjunct to proper dietary management, exercise, and weight reduction, or when insulin therapy is not appropriate. PRZ-METFORMIN can be used as monotherapy or in combination with other antidiabetic agents | 100 Tablets (Bottle) 500 Tablets (Bottle) | 100 Tablets (055668000800) 500 Tablets (055668001098) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Oblong | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-METFORMIN | 1000 mg | 02534673 | METFORMIN HYDROCHLORIDE | GLUCOPHAGE | Antihyperglycemic Agent |
Indication | Pack Size | UPC |
---|---|---|
PRZ-METFORMIN (metformin HCl) is indicated to improve glycemic control in adult patients with responsive, stable, mild, non-ketosis prone, type 2 diabetes mellitus as an adjunct to proper dietary management, exercise, and weight reduction, or when insulin therapy is not appropriate. PRZ-METFORMIN can be used as monotherapy or in combination with other antidiabetic agents | 100 Tablets (Bottle) 180 Tablets (Bottle) 500 Tablets (Bottle) | 100 Tablets (055668000787) 180 Tablets (055668001319) 500 Tablets (055668001302) |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White to Off-white | Deep convex | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-OLMESARTAN | 20 mg | 02505185 | OLMESARTAN MEDOXOMIL | OLMETEC | Angiotensin II AT1 Receptor Blocker |
Indication | Pack Size | UPC |
---|---|---|
PRZ-OLMESARTAN (olmesartan medoxomil) is indicated for the treatment of mild to moderate essential hypertension. PRZ-OLMESARTAN may be used alone or in combination with thiazide diuretic agents | Bottle of 100’s | 055668000091 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Round | Oral | No |
Product Name | Strength | DIN | Active Ingredient | Brand Reference | Therapeutic Class |
---|---|---|---|---|---|
PRZ-OLMESARTAN | 40 mg | 02505193 | OLMESARTAN MEDOXOMIL | OLMETEC | Angiotensin II AT1 Receptor Blocker |
Indication | Pack Size | UPC |
---|---|---|
PRZ-OLMESARTAN (olmesartan medoxomil) is indicated for the treatment of mild to moderate essential hypertension. PRZ-OLMESARTAN may be used alone or in combination with thiazide diuretic agents | Bottle of 100’s | 055668000107 |
Colour | Shape | Route of Administration | Refrigeration |
---|---|---|---|
White | Oval | Oral | No |
Need help finding information, we would love to hear from you
Please complete the form and we’ll get back to you within 1 – 2 business days.
Pharmaris Canada
8310 130th street, Unit 102 Surrey, BC, Canada, V3W 8J9
Phone: +1 866 913 7955
contactcanada@pharmaris.com
2020 – Pharmaris | All Rights Reserved